Avricore Health (AVCRF) Investment Income (2024 - 2026)

Avricore Health (AVCRF) has reported Investment Income for 3 consecutive years, with $487.97 the latest figure, recorded in Q2 2026.

• In Q2 2026, Investment Income rose 198.85% year-over-year to $487.97; the TTM figure through Jun 2026 stood at $375.93 (changed N/A YoY), while the FY2025 annual figure was -$66.56, down 93.9% from the prior year.
• Investment Income improved to $487.97 in Q2 2026 per AVCRF's latest filing, from $208.67 in the prior quarter.
• Across five years, Investment Income topped out at $487.97 in Q2 2026 and bottomed at -$493.65 in Q2 2025.
• Historically, Investment Income has averaged $63.73 across 3 years, with a median of $108.07 in 2025.
• Annual changes were most pronounced in 2025 — Investment Income surged 570.31% — and 2026, when it surged 198.85%.
• Avricore Health's Investment Income stood at -$36.77 in 2024, then soared by 667.49% to $208.67 in 2025, then soared by 133.85% to $487.97 in 2026.
• Business Quant data shows AVCRF's Investment Income at $487.97 in Q2 2026, $208.67 in Q4 2025, and $172.94 in Q3 2025.